Hemostats For Wound Closure Market
Description
Hemostats For Wound Closure Market
Historically wound types remain the same over the ages with only a slight exception being the emergence of femoral punctures associated with catheterization procedures. But with the advent of newer technologies the practice of closing those wounds are changed.
These new products are commonly available on hospitals & trauma centers and have wide range of usage area. Among them Hemostat has become a very popular tool to be used as wound closure material with its excellent properties. When applied to a wound, quickly absorbs blood and other body fluids, transforms into a gel to seal the wound with a protective transparent layer, actively aids in stopping bleeding, and creates an environment for wound healing.
Treatment of damaged cardiac tissue in patients with high bleeding tendency can be very challenging. In this category of surgery Hemostat proved to be a very effective with the combination of collagen sponge for the management of a myocardial wound
Topical hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Hemostats for Wound Closure: Drivers and Restraints
Wound closure has become a very frequent clinical practice which is growing very rapidly. The sophisticated procedures ensure rapid cessation of blood loss, prompt closure, strong adhesion of wound edges, tight sealing, reduced scarring, reduced risk of infection and more rapid healing. There is a pool of patients throughout the world which makes the market of this product is very lucrative. As the price is also very reasonable so acceptance of this product is gradually progressing.
On the other hand some reports come which could restrict the growth. Surgical staples are emerging as the most useful tool on this wound closure segment. Also the market of suture which is there traditionally remains constant if not growing to some parts of the world. Few reports also suggested that patients may suffer with irritation, heat inflammation or redness on skin when hemostat are applied, though its not clear the exact reason for these.
As the market is growing and price is low, so tough competitions will prevail in this segment too.
Hemostats for Wound Closure: Segmentation
Global market for wound closure products consist of hemostat are mainly driven the use of Fibrin which is the combination of thrombin & fibrinogen. Also collagen finds it use as hemostat though it still needs the approval of USFDA.
- Thrombin based Hemostats
- Combination Hemostats
- Oxidized Regenerated Cellulose Hemostats
- Gelatin Hemostats
- Collagen based Hemostats
With the rapid technological advancement in healthcare industry the Hemostats is expected to grow at a healthy CAGR in the forecasted period (2015-2025).
Hemostats for Wound Closure: Region-wise Outlook
Geographically, the wound closure products market has been segmented into seven major geographical regions which include North America, Eastern Europe, Western Europe, Asia Pacific exclude Japan, Japan & Latin America, Middle east & Africa. North America contribute the most in this market followed by Europe. With the new product approvals, change in regulatory policies encourages, patient acceptance helps the market to grow. Asia Pacific & Japan pose good growth potential too for wound closure products specially Hemostat.
Hemostats for Wound Closure: Key Players
Wound closure product market is highly fragmented with presence of big & small companies. The market leaders in this area are Johnson & Johnson, Covidien, B. Braun, and 3M.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Technology
- Value Chain
- North America (U.S., Canada)
- Latin America (Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands,
- Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa)
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
Table of Contents
250 Pages
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter’s Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
- 4. Global Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
- 5.3.1. Thrombin Based Hemostats
- 5.3.2. Combination Hemostats
- 5.3.3. Oxidized Regenerated Hemostats
- 5.3.4. Cellulose Based Hemostats
- 5.3.5. Gelatin Based Hemostats
- 5.3.6. Collagen Based Hemostats
- 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 6. Global Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By End User
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
- 6.3.1. Hospitals
- 6.3.2. Ambulatory Surgical Centers
- 6.3.3. Specialty Clinics
- 6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 7. Global Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 7.1. Introduction
- 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
- 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. East Asia
- 7.3.5. South Asia & Pacific
- 7.3.6. MEA
- 7.4. Market Attractiveness Analysis By Region
- 8. North America Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 8.2.1. By Country
- 8.2.1.1. U.K.
- 8.2.1.2. Canada
- 8.2.2. By Product Type
- 8.2.3. By End User
- 8.3. Market Attractiveness Analysis
- 8.3.1. By Country
- 8.3.2. By Product Type
- 8.3.3. By End User
- 8.4. Key Takeaways
- 9. Latin America Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 9.2.1. By Country
- 9.2.1.1. Brazil
- 9.2.1.2. Mexico
- 9.2.1.3. Rest of Latin America
- 9.2.2. By Product Type
- 9.2.3. By End User
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Product Type
- 9.3.3. By End User
- 9.4. Key Takeaways
- 10. Europe Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. Germany
- 10.2.1.2. U.K.
- 10.2.1.3. France
- 10.2.1.4. Spain
- 10.2.1.5. Italy
- 10.2.1.6. Rest of Europe
- 10.2.2. By Product Type
- 10.2.3. By End User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Product Type
- 10.3.3. By End User
- 10.4. Key Takeaways
- 11. East Asia Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. China
- 11.2.1.2. Japan
- 11.2.1.3. South Korea
- 11.2.2. By Product Type
- 11.2.3. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Product Type
- 11.3.3. By End User
- 11.4. Key Takeaways
- 12. South Asia & Pacific Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. India
- 12.2.1.2. Thailand
- 12.2.1.3. Indonesia
- 12.2.1.4. Malaysia
- 12.2.1.5. Singapore
- 12.2.1.6. Australia
- 12.2.1.7. New Zealand
- 12.2.1.8. Rest of South Asia & Pacific
- 12.2.2. By Product Type
- 12.2.3. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Product Type
- 12.3.3. By End User
- 12.4. Key Takeaways
- 13. MEA Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. GCC Countries
- 13.2.1.2. South Africa
- 13.2.1.3. Israel
- 13.2.1.4. Rest of MEA
- 13.2.2. By Product Type
- 13.2.3. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Product Type
- 13.3.3. By End User
- 13.4. Key Takeaways
- 14. Key Countries Hemostats For Wound Closure Market Analysis
- 14.1. U.K.
- 14.1.1. Pricing Analysis
- 14.1.2. Market Share Analysis, 2021
- 14.1.2.1. By Product Type
- 14.1.2.2. By End User
- 14.2. Canada
- 14.2.1. Pricing Analysis
- 14.2.2. Market Share Analysis, 2021
- 14.2.2.1. By Product Type
- 14.2.2.2. By End User
- 14.3. Brazil
- 14.3.1. Pricing Analysis
- 14.3.2. Market Share Analysis, 2021
- 14.3.2.1. By Product Type
- 14.3.2.2. By End User
- 14.4. Mexico
- 14.4.1. Pricing Analysis
- 14.4.2. Market Share Analysis, 2021
- 14.4.2.1. By Product Type
- 14.4.2.2. By End User
- 14.5. Germany
- 14.5.1. Pricing Analysis
- 14.5.2. Market Share Analysis, 2021
- 14.5.2.1. By Product Type
- 14.5.2.2. By End User
- 14.6. U.K.
- 14.6.1. Pricing Analysis
- 14.6.2. Market Share Analysis, 2021
- 14.6.2.1. By Product Type
- 14.6.2.2. By End User
- 14.7. France
- 14.7.1. Pricing Analysis
- 14.7.2. Market Share Analysis, 2021
- 14.7.2.1. By Product Type
- 14.7.2.2. By End User
- 14.8. Spain
- 14.8.1. Pricing Analysis
- 14.8.2. Market Share Analysis, 2021
- 14.8.2.1. By Product Type
- 14.8.2.2. By End User
- 14.9. Italy
- 14.9.1. Pricing Analysis
- 14.9.2. Market Share Analysis, 2021
- 14.9.2.1. By Product Type
- 14.9.2.2. By End User
- 14.10. China
- 14.10.1. Pricing Analysis
- 14.10.2. Market Share Analysis, 2021
- 14.10.2.1. By Product Type
- 14.10.2.2. By End User
- 14.11. Japan
- 14.11.1. Pricing Analysis
- 14.11.2. Market Share Analysis, 2021
- 14.11.2.1. By Product Type
- 14.11.2.2. By End User
- 14.12. South Korea
- 14.12.1. Pricing Analysis
- 14.12.2. Market Share Analysis, 2021
- 14.12.2.1. By Product Type
- 14.12.2.2. By End User
- 14.13. India
- 14.13.1. Pricing Analysis
- 14.13.2. Market Share Analysis, 2021
- 14.13.2.1. By Product Type
- 14.13.2.2. By End User
- 14.14. Thailand
- 14.14.1. Pricing Analysis
- 14.14.2. Market Share Analysis, 2021
- 14.14.2.1. By Product Type
- 14.14.2.2. By End User
- 14.15. Indonesia
- 14.15.1. Pricing Analysis
- 14.15.2. Market Share Analysis, 2021
- 14.15.2.1. By Product Type
- 14.15.2.2. By End User
- 14.16. Malaysia
- 14.16.1. Pricing Analysis
- 14.16.2. Market Share Analysis, 2021
- 14.16.2.1. By Product Type
- 14.16.2.2. By End User
- 14.17. Singapore
- 14.17.1. Pricing Analysis
- 14.17.2. Market Share Analysis, 2021
- 14.17.2.1. By Product Type
- 14.17.2.2. By End User
- 14.18. Australia
- 14.18.1. Pricing Analysis
- 14.18.2. Market Share Analysis, 2021
- 14.18.2.1. By Product Type
- 14.18.2.2. By End User
- 14.19. New Zealand
- 14.19.1. Pricing Analysis
- 14.19.2. Market Share Analysis, 2021
- 14.19.2.1. By Product Type
- 14.19.2.2. By End User
- 14.20. GCC Countries
- 14.20.1. Pricing Analysis
- 14.20.2. Market Share Analysis, 2021
- 14.20.2.1. By Product Type
- 14.20.2.2. By End User
- 14.21. South Africa
- 14.21.1. Pricing Analysis
- 14.21.2. Market Share Analysis, 2021
- 14.21.2.1. By Product Type
- 14.21.2.2. By End User
- 14.22. Israel
- 14.22.1. Pricing Analysis
- 14.22.2. Market Share Analysis, 2021
- 14.22.2.1. By Product Type
- 14.22.2.2. By End User
- 15. Market Structure Analysis
- 15.1. Competition Dashboard
- 15.2. Competition Benchmarking
- 15.3. Market Share Analysis of Top Players
- 15.3.1. By Regional
- 15.3.2. By Product Type
- 15.3.3. By End User
- 16. Competition Analysis
- 16.1. Competition Deep Dive
- 16.1.1. Johnson & Johnson Services, Inc.
- 16.1.1.1. Overview
- 16.1.1.2. Product Portfolio
- 16.1.1.3. Profitability by Market Segments
- 16.1.1.4. Sales Footprint
- 16.1.1.5. Strategy Overview
- 16.1.1.5.1. Marketing Strategy
- 16.1.2. Baxter
- 16.1.2.1. Overview
- 16.1.2.2. Product Portfolio
- 16.1.2.3. Profitability by Market Segments
- 16.1.2.4. Sales Footprint
- 16.1.2.5. Strategy Overview
- 16.1.2.5.1. Marketing Strategy
- 16.1.3. B. Braun Melsungen AG
- 16.1.3.1. Overview
- 16.1.3.2. Product Portfolio
- 16.1.3.3. Profitability by Market Segments
- 16.1.3.4. Sales Footprint
- 16.1.3.5. Strategy Overview
- 16.1.3.5.1. Marketing Strategy
- 16.1.4. Pfizer Inc.
- 16.1.4.1. Overview
- 16.1.4.2. Product Portfolio
- 16.1.4.3. Profitability by Market Segments
- 16.1.4.4. Sales Footprint
- 16.1.4.5. Strategy Overview
- 16.1.4.5.1. Marketing Strategy
- 16.1.5. Integra LifeSciences
- 16.1.5.1. Overview
- 16.1.5.2. Product Portfolio
- 16.1.5.3. Profitability by Market Segments
- 16.1.5.4. Sales Footprint
- 16.1.5.5. Strategy Overview
- 16.1.5.5.1. Marketing Strategy
- 16.1.6. Advanced Medical Solutions Group plc.
- 16.1.6.1. Overview
- 16.1.6.2. Product Portfolio
- 16.1.6.3. Profitability by Market Segments
- 16.1.6.4. Sales Footprint
- 16.1.6.5. Strategy Overview
- 16.1.6.5.1. Marketing Strategy
- 16.1.7. C. R. Bard, Inc.
- 16.1.7.1. Overview
- 16.1.7.2. Product Portfolio
- 16.1.7.3. Profitability by Market Segments
- 16.1.7.4. Sales Footprint
- 16.1.7.5. Strategy Overview
- 16.1.7.5.1. Marketing Strategy
- 16.1.8. Cresilon
- 16.1.8.1. Overview
- 16.1.8.2. Product Portfolio
- 16.1.8.3. Profitability by Market Segments
- 16.1.8.4. Sales Footprint
- 16.1.8.5. Strategy Overview
- 16.1.8.5.1. Marketing Strategy
- 16.1.9. Medtronic
- 16.1.9.1. Overview
- 16.1.9.2. Product Portfolio
- 16.1.9.3. Profitability by Market Segments
- 16.1.9.4. Sales Footprint
- 16.1.9.5. Strategy Overview
- 16.1.9.5.1. Marketing Strategy
- 16.1.10. Tissuemed Ltd
- 16.1.10.1. Overview
- 16.1.10.2. Product Portfolio
- 16.1.10.3. Profitability by Market Segments
- 16.1.10.4. Sales Footprint
- 16.1.10.5. Strategy Overview
- 16.1.10.5.1. Marketing Strategy
- 17. Assumptions & Acronyms Used
- 18. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


